Skip to main content

Publications

75 publications

Active

2 grants
  • MPI
    Neoadjuvant Tucatinib plus Trastuzumab in HER2-amplified Locally Advanced Rectal Cancer
    NCI · 2024–2029 · via NIH RePORTER
    R01CA288880-03
  • PI
    Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer
    NCI · 2022–2027 · via NIH RePORTER
    U01CA271287-04
Completed grants (2)
  • MPI
    Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)
    NCI · 2020–2025 · via NIH RePORTER
    U01CA238444-05
  • PI
    Neoadjuvant PD-1 blockade in mismatch repair deficient rectal cancer
    NCI · 2021–2024 · via NIH RePORTER
    R21CA252519-02